Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
523.91
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
147
Open
523.91
Bid (Size)
510.01 (40)
Ask (Size)
529.99 (40)
Prev. Close
523.91
Today's Range
523.91 - 523.91
52wk Range
362.50 - 546.17
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vertex (VRTX) Q2 2026 Earnings Call Transcript
↗
August 10, 2026
Revenue hit $3.3 billion with guidance raised on strong newer product growth.
Via
The Motley Fool
Topics
Earnings
Discover which S&P500 stocks are making waves on Monday.
↗
August 10, 2026
Via
Chartmill
Performance
YTD
+15.9%
+15.9%
1 Month
+9.1%
+9.1%
3 Month
+20.4%
+20.4%
6 Month
+11.3%
+11.3%
1 Year
+39.9%
+39.9%
More News
Read More
Explore the top gainers and losers within the S&P500 index in today's session.
↗
August 10, 2026
Via
Chartmill
Get insights into the top movers in the S&P500 index of Monday's pre-market session.
↗
August 10, 2026
Via
Chartmill
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth and Textbooks Technical Setup for Breakout
↗
July 29, 2026
Via
Chartmill
Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation
↗
July 21, 2026
Via
Chartmill
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call
August 10, 2026
Via
StockStory
Topics
Earnings
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?
↗
August 07, 2026
Via
The Motley Fool
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday
↗
August 04, 2026
Via
The Motley Fool
Vertex Pharmaceuticals Q2 Earnings Call Highlights
↗
August 03, 2026
Via
MarketBeat
Topics
Earnings
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations
August 03, 2026
Via
StockStory
Vertex Reports Second Quarter 2026 Financial Results
August 03, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For
August 01, 2026
Via
StockStory
Topics
Artificial Intelligence
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
↗
July 30, 2026
Via
The Motley Fool
Morgan Stanley Nearly Doubled Its Price Target for CRISPR Therapeutics. Is the Gene-Editing Stock a No-Brainer Buy?
↗
July 30, 2026
Via
The Motley Fool
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
July 29, 2026
From
AbCellera Biologics Inc.
Via
Business Wire
3 Healthcare Stocks with Competitive Advantages
July 23, 2026
Via
StockStory
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI)
July 21, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching
↗
July 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
1 Nasdaq 100 Stock to Keep an Eye On and 2 We Question
July 16, 2026
Via
StockStory
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
↗
July 15, 2026
Via
Benzinga
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
↗
July 14, 2026
Via
The Motley Fool
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
↗
July 13, 2026
Via
The Motley Fool
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
↗
July 11, 2026
Via
MarketBeat
Is This Biotech Stock a Buy Near Its 52-Week High?
↗
July 10, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 523.91
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 08/10/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 135.92B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 136B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
